LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Search

Lisata Therapeutics

Geschlossen

1.99 -1.49

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.8599999999999999

Max

2.02

Schlüsselkennzahlen

By Trading Economics

Angestellte

26

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+617.7% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.5M

16M

Vorheriger Eröffnungskurs

3.48

Vorheriger Schlusskurs

1.99

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Nov. 2025, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18. Nov. 2025, 18:09 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18. Nov. 2025, 17:39 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18. Nov. 2025, 16:25 UTC

Wichtige Markttreiber

Diginex Rises on Deal With Digital Asset Platform Evident

18. Nov. 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18. Nov. 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18. Nov. 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18. Nov. 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18. Nov. 2025, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18. Nov. 2025, 22:03 UTC

Ergebnisse

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. Nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. Nov. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. Nov. 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18. Nov. 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18. Nov. 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18. Nov. 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18. Nov. 2025, 18:29 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. Nov. 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18. Nov. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. Nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18. Nov. 2025, 17:19 UTC

Market Talk
Ergebnisse

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18. Nov. 2025, 17:06 UTC

Ergebnisse

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18. Nov. 2025, 16:06 UTC

Akquisitionen, Fusionen, Übernahmen

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18. Nov. 2025, 15:59 UTC

Ergebnisse

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18. Nov. 2025, 15:35 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18. Nov. 2025, 15:35 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Kursziel

By TipRanks

617.7% Vorteil

12-Monats-Prognose

Durchschnitt 15 USD  617.7%

Hoch 15 USD

Tief 15 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lisata Therapeutics – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Finanzen

$

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
help-icon Live chat